• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN GOOSENECK SNARE; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN GOOSENECK SNARE; CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stroke/CVA (1770)
Event Date 03/25/2019
Event Type  Injury  
Manufacturer Narrative
Date of publication journal article title: double homemade fenestrated stent graft for total endovascular aortic arch repair copyright _ 2019 by the society for vascular surgery.Published by elsevier inc.Https://doi.Org/10.1016/j.Jvs.2018.11.054.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Objective: the aim of this retrospective analysis was to evaluate the outcomes of physician-modified double fenestrated stent grafts for total endovascular aortic arch repair: one proximal large fenestration for the brachiocephalic trunk and the left common carotid artery and one distal fenestration for the left subclavian artery (lsa).Methods: from january 2017 through february 2018, 17 patients (88.2% elective) underwent thoracic endovascular aortic repair (tevar) with double homemade fenestrated stent graft for total endovascular aortic arch repair to maintain supraaortic trunk patency.Indications were degenerative aortic arch aneurysm (n = 7), dissecting aortic arch aneurysms subsequent to surgical treatment of acute type a dissections (n = 6), chronic complicated type b aortic dissection (n = 3), and acute complicated type b aortic dissection (n = 1).Routine postoperative follow-up imaging with computed tomography angiography was performed to assess tevar and supra-aortic trunks patency and endoleak.Results: the median time for stent graft modification was 19 minutes (range, 16-20 minutes).Endovascular exclusion of the aortic arch was achieved in all the cases.One lsa catheterization failed and lsa revascularization was performed by carotid axillary bypass and coverage of the lsa fenestration by additional stent graft placement.Additional planned endovascular procedures were required in three patients: closure of supra-aortic trunks re-entry tears in two cases of dissecting aortic arch aneurysms and one transcatheter aortic valve replacement for severe native aortic valve regurgitation.One stroke, with no long-term deficit, was observed.No patients died.All left supra-aortic trunks are patent.No type i endoleak was observed.We only observed one patient with a type ii endoleak.During a mean follow up of 7 6 2 months, there were no conversions to open surgical repair, aortic rupture, paraplegia, or retrograde dissection.Conclusions: double homemade fenestrated tevar is both feasible and effective for maintaining the patency of the supra-aortic trunks and allows total endovascular aortic arch repair.Durability concerns will need to be assessed in additional studies with long-term follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GOOSENECK SNARE
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9266807
MDR Text Key165628141
Report Number2183870-2019-00531
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K972511
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 11/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/10/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age70 YR
-
-